Fund Details
Overview
Investment portfolio
12rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Skopos Bio | Oct 2026Led | $8 MSeed | |
Chai Discovery | Jul 2026Participated | $400 MSeries C | |
Turquoise Health | Mar 2026Participated | $40 MSeries C | |
Proxima | Jan 2026Participated | $80 MSeed | |
Solve Therapeutics | Nov 2025Led | $120 MOther Equity | |
Azalea Therapeutics | Nov 2025Participated | $65 MSeries A | |
Sage Care | Oct 2025Led | $20 MOther Equity | |
Fourier Health | Oct 2025Led | $8 MSeed | |
Daymark Health | Sep 2025Participated | $20 MSeries A | |
Daymark Health | Apr 2025Led | $12 MSeed | |
Tune Therapeutics | Jan 2025Led | $175 MSeries B | |
Turquoise Health | Jan 2024Participated | $30 MSeries B | |
Skopos Bio | Oct 2026Led | $8 MSeed | |
Chai Discovery | Jul 2026Participated | $400 MSeries C | |
Turquoise Health | Mar 2026Participated | $40 MSeries C | |
Proxima | Jan 2026Participated | $80 MSeed | |
Solve Therapeutics | Nov 2025Led | $120 MOther Equity | |
Azalea Therapeutics | Nov 2025Participated | $65 MSeries A | |
Sage Care | Oct 2025Led | $20 MOther Equity | |
Fourier Health | Oct 2025Led | $8 MSeed | |
Daymark Health | Sep 2025Participated | $20 MSeries A | |
Daymark Health | Apr 2025Led | $12 MSeed | |
Tune Therapeutics | Jan 2025Led | $175 MSeries B | |
Turquoise Health | Jan 2024Participated | $30 MSeries B |
12 Items
12
Items
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 3 | 1 |
| Series A | 0 | 2 |
| Series B | 1 | 1 |
| Series C+ | 0 | 2 |
| Other Equity | 2 | 0 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jan '24 | 1 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 1 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 1 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 2 |
| Nov '25 | 2 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 1 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 1 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 1 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 12 |
| AI & Machine Learning | 3 |
| Fintech | 2 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 2 |
| $10M-$25M | 3 |
| $25M-$50M | 2 |
| $50M-$100M | 2 |
| $100M-$250M | 2 |
| $250M-$500M | 1 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 11 |
| Australia | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Adams Street Partners | 2 |
| Alexandria Venture Investments | 2 |
| Andreessen Horowitz | 2 |
| General Catalyst | 2 |
| Maverick Ventures | 2 |
| Oak HC/FT | 2 |
| Oncology Ventures | 2 |
| Abingworth | 1 |
| AIX Ventures | 1 |
| Ally Bridge Group | 1 |
| AME Cloud Ventures | 1 |
| Avenir | 1 |
| Avra Capital | 1 |
| AyurMaya | 1 |
| B Capital Group | 1 |
| Baillie Gifford | 1 |
| Bain Capital Ventures | 1 |
| Balyasny Asset Management | 1 |
| Battery Ventures | 1 |
| BlueCross BlueShield Venture Partners | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 6 | 50% |
| Participating | 6 | 50% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 3 | 50% |
| Co-led | 3 | 50% |